Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D Winocour

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Thrombosis and Haemostasis|March 11, 1998
BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatrobanC D Finkle, A St Pierre, L Leblond, et al.
Thrombosis Research|August 30, 2000
Incorporation of an Asp-Ser sequence to form an RGDS-like motif in hirutonin: the effect on in vitro platelet functionV van Wyk, L Leblond, P D Winocour, et al.
Atherosclerosis|March 1, 1989
Platelet function and survival in rats with genetically determined hypercholesterolaemiaP D Winocour, M L Rand, R L Kinlough-Rathbone, et al.
Arteriosclerosis (Dallas, Tex.)|November 1, 1982
Platelet survival and thrombosisP D Winocour, M Cattaneo, D Somers, et al.
Metabolism: Clinical and Experimental|January 24, 1998
Comparative catabolism of prothrombin and antithrombin in normal and alloxan-diabetic rabbitsM W Hatton, S M Southward, M A Blajchman, et al.
The Journal of Laboratory and Clinical Medicine|February 1, 1990
Thrombin-induced inositol phosphate production by platelets from rats with diet-induced or genetically determined hypercholesterolemiaP D Winocour, J D Vickers, R L Kinlough-Rathbone, et al.
Journal of Thrombosis and Thrombolysis|June 22, 1999
Antithrombotic effects of BCH 2763, a new direct thrombin inhibitor, in a canine model of venous thrombosisT B McClanahan, D P Ignasiak, P Juneau, et al.
Atherosclerosis|October 1, 1988
Thrombin binding to platelets from hypercholesterolaemic ratsP D Winocour, R L Kinlough-Rathbone, M L Rand, et al.
The Journal of Laboratory and Clinical Medicine|March 1, 1992
Altered levels of antithrombin III and fibrinogen in the aortic wall of the alloxan-induced diabetic rabbit: evidence of a prothrombotic stateM R Witmer, S J Hadcock, S L Peltier, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2001
Potent and selective bicyclic lactam inhibitors of thrombin. Part 4: transition state inhibitorsB Bachand, M Tarazi, Y St-Denis, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Thrombosis and Haemostasis|March 11, 1998
BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatrobanC D Finkle, A St Pierre, L Leblond, et al.
Thrombosis Research|August 30, 2000
Incorporation of an Asp-Ser sequence to form an RGDS-like motif in hirutonin: the effect on in vitro platelet functionV van Wyk, L Leblond, P D Winocour, et al.
Atherosclerosis|March 1, 1989
Platelet function and survival in rats with genetically determined hypercholesterolaemiaP D Winocour, M L Rand, R L Kinlough-Rathbone, et al.
Arteriosclerosis (Dallas, Tex.)|November 1, 1982
Platelet survival and thrombosisP D Winocour, M Cattaneo, D Somers, et al.
Metabolism: Clinical and Experimental|January 24, 1998
Comparative catabolism of prothrombin and antithrombin in normal and alloxan-diabetic rabbitsM W Hatton, S M Southward, M A Blajchman, et al.
The Journal of Laboratory and Clinical Medicine|February 1, 1990
Thrombin-induced inositol phosphate production by platelets from rats with diet-induced or genetically determined hypercholesterolemiaP D Winocour, J D Vickers, R L Kinlough-Rathbone, et al.
Journal of Thrombosis and Thrombolysis|June 22, 1999
Antithrombotic effects of BCH 2763, a new direct thrombin inhibitor, in a canine model of venous thrombosisT B McClanahan, D P Ignasiak, P Juneau, et al.
Atherosclerosis|October 1, 1988
Thrombin binding to platelets from hypercholesterolaemic ratsP D Winocour, R L Kinlough-Rathbone, M L Rand, et al.
The Journal of Laboratory and Clinical Medicine|March 1, 1992
Altered levels of antithrombin III and fibrinogen in the aortic wall of the alloxan-induced diabetic rabbit: evidence of a prothrombotic stateM R Witmer, S J Hadcock, S L Peltier, et al.
Bioorganic & Medicinal Chemistry Letters|February 24, 2001
Potent and selective bicyclic lactam inhibitors of thrombin. Part 4: transition state inhibitorsB Bachand, M Tarazi, Y St-Denis, et al.
Pageof 6